Reductions in body weight ( -4.1 % , -4.2 % , and 0.9 % , respectively ) and systolic blood pressure ( -2.0 , -3.1 , and 1.7 mmHg , respectively ) were seen with canagliflozin 100 and 300 mg compared with glimepiride at week 104 .